✦ LIBER ✦

Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study

✍ Scribed by Giles, Francis J; Rosti, Gianantonio; Beris, Photis; Clark, Richard E; le Coutre, Philipp; Mahon, Francois-Xavier; Steegmann, Juan-Luis; Valent, Peter; Saglio, Giuseppe

Book ID: 121089776
Publisher: Expert Reviews
Year: 2010
Tongue: English
Weight: 731 KB
Volume: 3
Category: Article
ISSN: 1747-4086
DOI: 10.1586/ehm.10.61

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN60 Cost Effectiveness of Nilotinib, D

PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011

✍ Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Di 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Nilotinib as frontline therapy for patie

Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd

✍ Hirohisa Nakamae; Hirohiko Shibayama; Mineo Kurokawa; Tetsuya Fukuda; Chiaki Nak 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 289 KB

Cost-Utility Analysis of Dasatinib and N

Cost-Utility Analysis of Dasatinib and Nilotinib in Patients With Chronic Myeloid Leukemia Refractory to First-Line Treatment With Imatinib in Thailand

✍ Kulpeng, Wantanee; Sompitak, Sumalai; Jootar, Saengsuree; Chansung, Kanchana; Te 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 433 KB

PCN63 The Relative Value of Dasatinib Ve

PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia

✍ L. Betegon; I. Gilloteau; P. Martin; A. Woolmore; I. Oyagüez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN92 Cost-Effectiveness of Nilotinib Ve

PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation

✍ R. Yagudina; A. Kulikov; I. Komarov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Imatinib as the first-line treatment of

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

✍ Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views